Surgical outcomes following neoadjuvant chemotherapy with and without immunotherapy in patients with triple-negative breast cancer

By sjmartinez • September 21, 2024

Holt AC, Smith CA, Berkowitz MJ, Baker JL, McAndrew NP, Kapoor NS. Surgical outcomes following neoadjuvant chemotherapy with and without immunotherapy in patients with triple-negative breast cancer. Discov Oncol. 2024 Sep 20;15(1):467. doi: 10.1007/s12672-024-01349-7. PMID: 39302495; PMCID: PMC11415316.

Tags: Hematology/Oncology, Neoadjuvant immunotherapy, Publications, surgical outcomes, TNBC

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

Hoff FW, Huang Y, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Patel PA, Collins RH Jr, Baer MR, Duong VH, Blum WG,[...]

Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial

Van Gorp T, Moore KN, Konecny GE, Leary A, García-García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Caruso G, Klasa-Mazurkiewicz D, Tromp J,[...]

Association of lipoprotein(a) and diabetes in primary prevention of coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA)

Rikhi R, Haidar A, Bhatia HS, Beam K, McParland J, Kazibwe R, Chevli P, Schaich CL, Sanghavi M, Shapiro MD. Association of lipoprotein(a) and diabetes[...]